Navigation Links
Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter
Date:2/14/2011

908 469 1788

P: + 61 2 8346 6500(Tables Below)UNILIFE CORPORATION AND SUBSIDIARIESConsolidated Balance Sheets(in thousands, except share data)(unaudited)AssetsDecember 31,
2010June 30,
2010Current Assets:Cash and cash equivalents

$39,133$20,750Restricted cash

2,400—Accounts receivable

4511,556Inventories

1,028797Prepaid expenses and other current assets

745637Total current assets

43,75723,740Property, plant and equipment, net

49,81029,972Goodwill

12,73610,792Intangible assets, net

4440Other assets

502273Total assets

$106,849$64,817Liabilities and Stockholders’ EquityCurrent Liabilities:Accounts payable

$3,671$6,044Accrued expenses

3,5712,911Current portion of long-term debt

2,2011,648Deferred revenue

2,5952,188Total current liabilities

12,03812,791Long-term debt, less current portion

16,3771,093Deferred revenue

6,4886,563Total liabilities

34,90320,447Stockholders’ Equity:Preferred stock, $0.01 par value, 50,000,000 shares authorized as of December 31, 2010; none issued or outstanding as of December 31, 2010 and June 30, 2010

——Common stock, $0.01 par value, 250,000,000 shares authorized as of December 31, 2010; 63,397,161 and 54,761,848 shares issued and outstanding as of December 31, 2010 and June 30, 2010, respectively

634548Additional paid-in-capital

164,597122,397Accumulated deficit

(97,254)(79,650)Accumulated other comprehensive income

3,9691,075Total stockholders’ equity

71,94644,370Total liabilities and stockholders’ equity

$106,849$64,817UNILIFE CORPORATION AND SUBSIDIARIESConsolidated Statements of Operations(in thousands, except per share data)(unaudited)Three Months EndedSix Months EndedDecember 31, December 31, 2010200920102009Revenues:Industrialization fees

$
8212;$2,088$1,350$3,833Licensing fees

6
'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Unilife Corporation Commences Trading on the NASDAQ Global Market Under the Ticker Symbol UNIS
2. Unilife Corporation Schedules Fiscal 2010 Fourth Quarter and Year End Conference Call for Monday, August 30, 2010
3. Unilife Corporation Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2010
4. Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe
5. Unilife Secures U.S. Government Financial Backing for the Completion of New Global Headquarters and Manufacturing Facility in York, PA
6. Unilife Corporation Schedules Fiscal 2011 First Quarter Conference Call For Monday, November 15, 2010
7. Unilife Commences U.S. Sales of Unitract® 1mL Syringes
8. Unilife Corporation Announces Financial Results for Fiscal Year 2011 First Quarter
9. Unilife Completes A$23.1 Million Private Placement
10. Unilife Corporation Moves into New State-of-the-Art Manufacturing Facility and Global Headquarters
11. Unilife Receives SPP Applications Exceeding A$12.8 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)...  Zacks.com announces the list of stocks featured in the ... the latest news and events impacting stocks and the financial ... BIIB - Free Report ), Gilead (Nasdaq: GILD ... Free Report ), AbbVie (NYSE: ABBV - Free Report ... Today, Zacks is promoting its ,Buy, stock recommendations. ...
(Date:7/31/2014)... AUSTIN, Texas , July 31, 2014 Vermillion, ... cancers and women,s health, will hold a conference call on ... discuss results for the second quarter ended June 30, 2014. ... to the call. Vermillion,s Chairman, President and CEO ... a question and answer period. Date: Thursday, August ...
(Date:7/31/2014)... TB Alliance, a not-for-profit with the ... affordable treatments, announced the appointment of Willo ... Mr. Brock comes to TB Alliance having most ... for WWF International (formerly known as the World ... guide the TB Alliance,s resource development, advocacy and ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... June 14, 2011 Orthopedics This Week announced today ... News to supply Orthopedics This Week, the #1 source ... terminal subscribers including some of the most prominent investors ... The Bloomberg network includes portfolio managers, central bankers, finance ...
... 2011 Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX ... the U.S. Food and Drug Administration (FDA) has extended ... for its review of the New Drug Application (NDA) ... The new PDUFA goal date is October 28, 2011. ...
Cached Medicine Technology:Orthopedics This Week Now on Bloomberg 2Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months 2Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months 3
(Date:7/31/2014)... 31, 2014 Dr. Andrew Lian-Jie Li ... of Dermatology, fellowship trained Mohs surgeon that has been ... , After extensive dermatology research training at the National ... Li completed his internship in internal medicine at the ... Pennsylvania in Philadelphia. Dr. Li pursued further training in ...
(Date:7/31/2014)... prevalence of heroin use has been rising steadily in ... Survey on Drug Use and Health, the number of ... 2007 (373,000) and 2012 (669,000). Emerging evidence suggests the ... who transition from oral and/or intranasal PO use to ... opioid use, and ultimately, heroin injection. This drug-use ...
(Date:7/31/2014)... Model moms are believers. PBS has a ... in the field have grown exponentially in the last two ... industry, there are associated myths that need to be busted. ... Frontier Nursing University . Celebrating 75 years in 2014, Frontier ... in the nation. “Frontier is changing the face of healthcare ...
(Date:7/31/2014)... UK (PRWEB) July 31, 2014 Infection ... the development and maintenance of products in the pharma, ... be performed by using various products and equipment types; ... spoilage of various materials and products. , The ... services is forecast to post a CAGR of about ...
(Date:7/31/2014)... By Amy Norton ... -- They may not have had fast food, TVs or ... arteries -- and a new research review speculates on some ... ancient Egypt, Peru, the Aleutian Islands and the American Southwest, ... of heart arteries from fatty substances that build up, eventually ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Proudly Presents Approved Provider, Dr. Andrew Li of Warren Skin Care Center 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 2Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 3Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 4Health News:Frontier Nursing University Busts Midwifery Myths In Celebration of 75th Anniversary 5Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 2Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 3Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 2Health News:No TV or Obesity, But Ancient People Still Had Heart Disease 3
... group of immature cells that persist in the adult ... mice that these cells undergo dramatic changes in ALS, ... reported November 17 online in Neuron shows that these ... life, eventually morphing into mature nervous system cells called ...
... HealthDay Reporter , WEDNESDAY, Nov. 17 (HealthDay News) -- ... a striking effect on lowering blood pressure in heart ... drugs, Australian researchers report. Although this study only ... -- the authors believe the approach, which involves delivering ...
... Nov. 17 (HealthDay News) -- A new drug focused on the ... clinical trials, new research shows. If eventually approved by ... VX-770 would mark the first treatment that gets at what ... than just the symptoms. Only 4 to 5 percent of ...
... , WEDNESDAY, Nov. 17 (HealthDay News) -- Resistance ... than aerobic exercise and offers other cardiovascular benefits, finds ... University in Boone, N.C., compared blood vessel (vascular) responses ... 10 repetitions of eight resistance exercises and 30 minutes ...
... 17 (HealthDay News) -- The U.S. Food and Drug Administration ... products are illegal. In warning letters to the companies, ... is an "unsafe food additive," and the companies risked further ... find support for the claim that the addition of caffeine ...
... to targeting diseases such as cancer has been announced by ... the potential for more targeted treatments following their identification of ... a human cell. The research teams from Germany and ... Publication on Nature Cell Biology ,s website. ...
Cached Medicine News:Health News:Mysterious cells may play role in ALS 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 3Health News:Drug Targets Faulty Process That Drives Cystic Fibrosis 2Health News:Drug Targets Faulty Process That Drives Cystic Fibrosis 3Health News:Resistance Exercise May Offer Different Cardio Benefits 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 3Health News:Scientists announce new advance with potential for future cancer targeting 2
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
... Bench high, 26-31". Ergonomic design increases ... pnuematic control for easy height adjustment. ... allow easy mobility. Fixed footring standard. ... 5000 Volts to technical zero); ...
Inquire...
Medicine Products: